CDFS-JPSK
Phase 2
Completed
- Conditions
- Aneurysmal subarachnoid hemorrhage (aSAH)
- Registration Number
- JPRN-jRCT2080222837
- Lead Sponsor
- Actelion Pharmaceuticals Japan Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 168
Inclusion Criteria
patients treated by surgical clipping
WFNS GradeI - IV
Fisher group 3
Exclusion Criteria
Presence of cerebral vasospasm seen prior to the clipping procedure etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method